Your browser doesn't support javascript.
loading
Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer.
Ligumsky, Hagai; Dor, Herut; Etan, Tal; Golomb, Inbal; Nikolaevski-Berlin, Alla; Greenberg, Inbal; Halperin, Tamar; Angel, Yoel; Henig, Oryan; Spitzer, Avishay; Slobodkin, Marina; Wolf, Ido.
Afiliação
  • Ligumsky H; Oncology Division, Tel Aviv Sourasky Medical Center 6423906, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: hagail@tlvmc.gov.il.
  • Dor H; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Etan T; Oncology Division, Tel Aviv Sourasky Medical Center 6423906, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Golomb I; Oncology Division, Tel Aviv Sourasky Medical Center 6423906, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Nikolaevski-Berlin A; Oncology Division, Tel Aviv Sourasky Medical Center 6423906, Tel Aviv, Israel.
  • Greenberg I; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Halperin T; Human Immunodeficiency Virus Laboratory, Tel Aviv Sourasky Medical Center 6423906, Tel Aviv, Israel.
  • Angel Y; Department of Anasthesia, Pain and Intensive Care, Tel Aviv Sourasky Medical Center 6423906, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Henig O; Department of Infectious Diseases and Infection Control, Tel Aviv Sourasky Medical Center 6423906, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Spitzer A; Oncology Division, Tel Aviv Sourasky Medical Center 6423906, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
  • Slobodkin M; Department of Internal Medicine "D", Tel Aviv Sourasky Medical Center 6423906, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Wolf I; Oncology Division, Tel Aviv Sourasky Medical Center 6423906, Tel Aviv, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Lancet Oncol ; 23(2): 193-195, 2022 02.
Article em En | MEDLINE | ID: mdl-34953523
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunização Secundária / Imunogenicidade da Vacina / Vacina BNT162 / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunização Secundária / Imunogenicidade da Vacina / Vacina BNT162 / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article